mevalonic acid and Diabetic Angiopathies

mevalonic acid has been researched along with Diabetic Angiopathies in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, HJ; Kim, HS; Kim, SJ; Kwon, YW; Lee, HY; Lee, SW; Oh, BH; Park, YB; Youn, SW	1
Danesh, FR; Kanwar, YS	1

Reviews

1 review(s) available for mevalonic acid and Diabetic Angiopathies

Article	Year
Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2004, Volume: 18, Issue:7 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cholesterol; Diabetic Angiopathies; Diabetic Nephropathies; Endothelium, Vascular; Enzyme Induction; GTP Phosphohydrolases; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Insulin Resistance; Mevalonic Acid; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Protein Prenylation; Protein Processing, Post-Translational; Rabbits; Rats; Rhabdomyolysis; Signal Transduction; Terpenes	2004

Article

Year

Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2004, Volume: 18, Issue:7

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cholesterol; Diabetic Angiopathies; Diabetic Nephropathies; Endothelium, Vascular; Enzyme Induction; GTP Phosphohydrolases; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Insulin Resistance; Mevalonic Acid; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Protein Prenylation; Protein Processing, Post-Translational; Rabbits; Rats; Rhabdomyolysis; Signal Transduction; Terpenes

2004

Other Studies

1 other study(ies) available for mevalonic acid and Diabetic Angiopathies

Article	Year
FOXO1 impairs whereas statin protects endothelial function in diabetes through reciprocal regulation of Kruppel-like factor 2. Cardiovascular research, 2013, Jan-01, Volume: 97, Issue:1 Topics: Animals; Atorvastatin; Base Sequence; Binding Sites; Blood Glucose; Cells, Cultured; Chromatin Immunoprecipitation; Cytoprotection; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Forkhead Box Protein O1; Forkhead Transcription Factors; Gene Expression Regulation; Heptanoic Acids; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kruppel-Like Transcription Factors; Male; Mevalonic Acid; Molecular Sequence Data; Nerve Tissue Proteins; Nitric Oxide Synthase Type III; Phosphorylation; Promoter Regions, Genetic; Pyrroles; Rats; Rats, Inbred OLETF; RNA Interference; Time Factors; Transfection; Vasodilation; Vasodilator Agents	2013

Article

Year

FOXO1 impairs whereas statin protects endothelial function in diabetes through reciprocal regulation of Kruppel-like factor 2.

Cardiovascular research, 2013, Jan-01, Volume: 97, Issue:1

Topics: Animals; Atorvastatin; Base Sequence; Binding Sites; Blood Glucose; Cells, Cultured; Chromatin Immunoprecipitation; Cytoprotection; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Forkhead Box Protein O1; Forkhead Transcription Factors; Gene Expression Regulation; Heptanoic Acids; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kruppel-Like Transcription Factors; Male; Mevalonic Acid; Molecular Sequence Data; Nerve Tissue Proteins; Nitric Oxide Synthase Type III; Phosphorylation; Promoter Regions, Genetic; Pyrroles; Rats; Rats, Inbred OLETF; RNA Interference; Time Factors; Transfection; Vasodilation; Vasodilator Agents

2013